New tools for achieving tuberculosis control: progress and reflexion.
暂无分享,去创建一个
[1] Eduardo Gotuzzo,et al. Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.
[2] A. Nunn,et al. Global tuberculosis drug development pipeline: the need and the reality , 2010, The Lancet.
[3] S. Kaufmann,et al. New vaccines for tuberculosis , 2010, The Lancet.
[4] Alimuddin Zumla,et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice , 2010, The Lancet.
[5] Alimuddin Zumla,et al. Trials and tribulations of an African‐led research and capacity development programme: the case for EDCTP investments , 2010, Tropical medicine & international health : TM & IH.
[6] M. Raviglione,et al. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes , 2010, Current opinion in pulmonary medicine.
[7] Irene Ayakaka,et al. Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology , 2009, Journal of Clinical Microbiology.
[8] Alimuddin Zumla,et al. Biomarkers for tuberculosis disease status and diagnosis , 2009, Current opinion in pulmonary medicine.
[9] S. Kaufmann,et al. Tuberculosis in Africa: learning from pathogenesis for biomarker identification. , 2008, Cell host & microbe.
[10] Dirk Repsilber,et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis , 2007, Journal of Molecular Medicine.
[11] P. Farmer,et al. Historical declines in tuberculosis: nature, nurture and the biosocial model. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[12] D Repsilber,et al. Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.